Targeting Estrogen Receptor (ER) Mutations for Treatment of Endocrine Therapy Resistance in Breast Cancer

被引：1
|
作者：
Alluri, P. G. [1 ]
Larios, J. [1 ]
Malik, R. [1 ]
Rae, J. [1 ]
Chinnaiyan, A. [2 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.139
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
118
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [1] Targeting estrogen receptor mutations for treatment of endocrine therapy resistance in breast cancer
    Alluri, Prasanna G.
    Larios, Jose
    Malik, Rohit
    Rae, James
    Chiinaiyan, Arul M.
    CANCER RESEARCH, 2016, 76
  • [2] Targeting estrogen receptor mutations for treatment of endocrine therapy resistance in breast cancer
    Alluri, P. G.
    Larios, J. M.
    Malik, R.
    Hayes, D. F.
    Speers, C. W.
    Rae, J. M.
    Chinnaiyan, A. M.
    CANCER RESEARCH, 2017, 77
  • [3] Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
    De Marchi, Tommaso
    Foekens, John A.
    Umar, Arzu
    Martens, John W. M.
    DRUG DISCOVERY TODAY, 2016, 21 (07) : 1181 - 1188
  • [4] Selective Estrogen Receptor Degraders (SERDs): A Promising Treatment to Overcome Resistance to Endocrine Therapy in ERα-Positive Breast Cancer
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (11): : 1129 - 1131
  • [5] Targeting tyrosine-kinases and estrogen receptor abrogates resistance to endocrine therapy in breast cancer
    Liu, Shuying
    Meng, Xiaolong
    Chen, Huiqin
    Liu, Wenbin
    Miller, Todd
    Murph, Mandi
    Lu, Yiling
    Zhang, Fan
    Gagea, Mihai
    Arteaga, Carlos L.
    Mills, Gordon B.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    ONCOTARGET, 2014, 5 (19) : 9049 - 9064
  • [6] The Central Contributions of Breast Cancer Stem Cells in Developing Resistance to Endocrine Therapy in Estrogen Receptor (ER)-Positive Breast Cancer
    Rodriguez, David
    Ramkairsingh, Marc
    Lin, Xiaozeng
    Kapoor, Anil
    Major, Pierre
    Tang, Damu
    CANCERS, 2019, 11 (07)
  • [7] Micro-RNAs targeting the estrogen receptor alpha involved in endocrine therapy resistance in breast cancer
    Marquez-Mendoza, J. M.
    Baranda-Avila, N.
    Lizano, M.
    Langley, E.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2025, 1871 (05):
  • [8] Endocrine therapy resistance can be associated with high estrogen receptor α (ERα) expression and reduced ERα phosphorylation in breast cancer models
    Kuske, Barbara
    Naughton, Catherine
    Moore, Kate
    MacLeod, Kenneth G.
    Miller, William R.
    Clarke, Robert
    Langdon, Simon P.
    Cameron, David A.
    ENDOCRINE-RELATED CANCER, 2006, 13 (04) : 1121 - 1133
  • [9] PARP inhibition effects on endocrine therapy and resistance in estrogen receptor positive (ER plus ) breast cancer models
    Nardone, Agostina
    Goldstein, Amit
    Shea, Martin J.
    Mithchell, Tamika
    Fu, Xiaoyong
    De Angelis, Carmine
    Hu, Huizhong
    Xu, Xiaowei
    Rajendran, Mahitha
    O'Connor, Mark
    Locker, Gershon
    Hilsenbeck, Susan
    Osborne, Kent
    Schiff, Rachel
    CANCER RESEARCH, 2015, 75
  • [10] Estrogen receptor gene fusions drive endocrine therapy resistance in estrogen receptor positive breast cancer
    Lei, Jonathan T.
    Shao, Jieya
    Zhang, Jin
    Iglesia, Michael
    Chan, Doug W.
    Matsunuma, Ryoichi
    He, Xiaping
    Singh, Purba
    Kosaka, Yoshimasa
    Crowder, Robert
    Haricharan, Svasti
    Kavuri, Shyam
    Hoog, Jeremy
    Phommaly, Chanpheng
    Goncalves, Rodrigo
    Romalho, Susana
    Lai, Wei-Chu
    Hampton, Oliver
    Rogers, Anna
    Tobias, Ethan
    Parikh, Poojan
    Davies, Sherri
    Ma, Cynthia
    Suman, Vera
    Hunt, Kelly
    Watson, Mark
    Hoadley, Katherine A.
    Thompson, Aubrey
    Perou, Charles
    Creighton, Chad J.
    Maher, Chris
    Ellis, Matthew J.
    CANCER RESEARCH, 2017, 77
12345